Literature DB >> 3473276

Highly transformable mutants of Streptomyces fradiae defective in several restriction systems.

P Matsushima, K L Cox, R H Baltz.   

Abstract

Streptomyces fradiae JS85 is a mutant defective in tylosin production and an efficient recipient for conjugal transfer of tylosin genes. JS85 was mutagenized with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and derivatives defective in restriction were isolated by sequential selection for increased transformability by several plasmid DNAs. From the number of mutation and selection cycles required to eliminate most restriction, it was estimated that wild type S. fradiae expressed at least five restriction systems. From the patterns of restriction enzyme digestion of chromosomal DNA observed in the series of mutants that became progressively less restricting, it was suggested that wild type S. fradiae normally expresses modification (and presumably restriction) systems similar or analogous to PstI, XhoI, ScaI and EcoRI. The least restricting mutant of S. fradiae was readily transformable by many plasmids, including a bifunctional cosmid vector containing a large insert of Streptomyces DNA.

Entities:  

Mesh:

Year:  1987        PMID: 3473276     DOI: 10.1007/BF00428877

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  21 in total

1.  Cosmid shuttle vectors for cloning and analysis of Streptomyces DNA.

Authors:  R N Rao; M A Richardson; S Kuhstoss
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

2.  Mutagenic DNA repair in Streptomyces.

Authors:  J Stonesifer; R H Baltz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

3.  Restriction of bacteriophage plaque formation in Streptomyces spp.

Authors:  K L Cox; R H Baltz
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

4.  DNA cloning in Streptomyces: resistance genes from antibiotic-producing species.

Authors:  C J Thompson; J M Ward; D A Hopwood
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

5.  Genetics and biochemistry on tylosin production: a model for genetic engineering in antibiotic-producing Streptomyces.

Authors:  R H Baltz
Journal:  Basic Life Sci       Date:  1982

6.  Streptomyces albus G mutants defective in the SalGI restriction-modification system.

Authors:  K F Chater; L C Wilde
Journal:  J Gen Microbiol       Date:  1980-02

7.  Protoplast fusion in Streptomyces: conditions for efficient genetic recombination and cell regeneration.

Authors:  R H Baltz; P Matsushima
Journal:  J Gen Microbiol       Date:  1981-11

8.  Phenotypic changes associated with loss of expression of tylosin biosynthesis and resistance genes in Streptomyces fradiae.

Authors:  R H Baltz; J Stonesifer
Journal:  J Antibiot (Tokyo)       Date:  1985-09       Impact factor: 2.649

9.  Efficient plasmid transformation of Streptomyces ambofaciens and Streptomyces fradiae protoplasts.

Authors:  P Matsushima; R H Baltz
Journal:  J Bacteriol       Date:  1985-07       Impact factor: 3.490

10.  Properties of S-adenosyl-L-methionine:macrocin O-methyltransferase in extracts of Streptomyces fradiae strains which produce normal or elevated levels of tylosin and in mutants blocked in specific O-methylations.

Authors:  E T Seno; R H Baltz
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

View more
  18 in total

1.  Secretion by overexpression and purification of the water-soluble Streptomyces K15 DD-transpeptidase/penicillin-binding protein.

Authors:  P Palomeque-Messia; V Quittre; M Leyh-Bouille; M Nguyen-Distèche; C J Gershater; I K Dacey; J Dusart; J Van Beeumen; J M Ghuysen
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

Review 2.  Streptomyces and Saccharopolyspora hosts for heterologous expression of secondary metabolite gene clusters.

Authors:  Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2010-05-14       Impact factor: 3.346

3.  Transduction of plasmid DNA in Streptomyces spp. and related genera by bacteriophage FP43.

Authors:  M A McHenney; R H Baltz
Journal:  J Bacteriol       Date:  1988-05       Impact factor: 3.490

4.  Incompatibility of Lactobacillus Vectors with Replicons Derived from Small Cryptic Lactobacillus Plasmids and Segregational Instability of the Introduced Vectors.

Authors:  M Posno; R J Leer; N van Luijk; M J F van Giezen; P T H M Heuvelmans; B C Lokman; P H Pouwels
Journal:  Appl Environ Microbiol       Date:  1991-06       Impact factor: 4.792

Review 5.  The impact of genetic engineering on the commercial production of antibiotics by Streptomyces and related bacteria.

Authors:  C R Hutchinson
Journal:  Appl Biochem Biotechnol       Date:  1987 Sep-Dec       Impact factor: 2.926

6.  Cloning of spiramycin biosynthetic genes and their use in constructing Streptomyces ambofaciens mutants defective in spiramycin biosynthesis.

Authors:  M A Richardson; S Kuhstoss; M L Huber; L Ford; O Godfrey; J R Turner; R N Rao
Journal:  J Bacteriol       Date:  1990-07       Impact factor: 3.490

Review 7.  Bacteriophage-resistant industrial fermentation strains: from the cradle to CRISPR/Cas9.

Authors:  Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2018-09-06       Impact factor: 3.346

8.  Isolation and identification of Streptomyces fradiae SU-1 from Thailand and protoplast transformation with the chitinase B Gene from Nocardiopsis prasina OPC-131.

Authors:  Busaya Apichaisataienchote; Josef Altenbuchner; Heinrich Buchenauer
Journal:  Curr Microbiol       Date:  2005-07-05       Impact factor: 2.188

9.  Molecular cloning with a pMEA300-derived shuttle vector and characterization of the Amycolatopsis methanolica prephenate dehydratase gene.

Authors:  J W Vrijbloed; J van Hylckama Vlieg; N M van der Put; G I Hessels; L Dijkhuizen
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

10.  Streptomyces lipmanii expresses two restriction systems that inhibit plasmid transformation and bacteriophage plaque formation.

Authors:  P Matsushima; R H Baltz
Journal:  J Bacteriol       Date:  1989-06       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.